| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |